Real-world Data Study of the Efficacy and Toxicity of Nivolumab vs . Cetuximab and Predictors of Response to Nivolumab in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck in a European Population.

Autor: Macia-Rivas L; Universidad de Santiago de Compostela, A Coruña, Spain; lolamaciarivas@gmail.com.; Pharmacy Department, Hospital Universitario Central de Asturias, Oviedo, Spain., Fernandez-Laguna CL; Pharmacy Department, Hospital Universitario Central de Asturias, Oviedo, Spain., Alvarez-Asteinza C; Pharmacy Department, Hospital Universitario Central de Asturias, Oviedo, Spain., Maray I; Pharmacy Department, Hospital Universitario Central de Asturias, Oviedo, Spain., Carbajales-Alvarez M; Pharmacy Department, Hospital Universitario Central de Asturias, Oviedo, Spain., Lozano-Blazquez A; Pharmacy Department, Hospital Universitario Central de Asturias, Oviedo, Spain.

Publikováno v: Anticancer research [Anticancer Res] 2023 Apr; Vol. 43 (4), pp. 1681-1688.